Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
5
×
life sciences
national blog main
new york blog main
new york top stories
5
×
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
national top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
curevac
investing
nonalcoholic steatohepatitis
aegle therapeutics
aligos therapeutics
alzheimer's disease
amag pharmaceuticals
aquestive therapeutics
arch venture partners
What
cancer
5
×
bio
roundup
promise
vaccine
amid
bombast
cash
caught
coronavirus
debate
develop
discussion
efforts
hasn’t
meso’s
miss
pandemic
pfizer’s
pharmaceutical
presidential
response
tuesday’s
viewers
ahead
ambien
american
annual
appetite
asco
attendees
attention
bets
biotech
black
bread
butter
buyout
camp’s
chicago
Language
unset
Current search:
cancer
×
" new york top stories "
×
deals
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More